Treatment of glioblastoma in Germany
Innovative approaches to the treatment of aggressive brain tumors: from navigational surgery to immunotherapy
Glioblastoma (GBM) is the most aggressive primary brain tumor (WHO grade IV). At RheinRegio Klinik Zentrum, combined treatment protocols are used, including intraoperative fluorescence, proton therapy and targeted drugs. Our goal is to maximize life extension while maintaining its quality.
Symptoms of glioblastoma
General cerebral manifestations
- Headache (worsens in the morning, not relieved by analgesics)
- Nausea and vomiting without relief
- Seizures (in 50% of cases)
Focal symptoms
- Paresis of the limbs (if localized in the motor cortex)
- Speech disorders (temporal lobe tumors)
- Visual hallucinations (occipital lobe damage)
Critical sign: Rapid increase in symptoms over 2-3 months.
Diagnosis of glioblastoma at RheinRegio Klinik Zentrum
At RheinRegio Klinik Zentrum we carry out:
- MRI with contrast (typical picture of “rings with jagged edges”)
- Perfusion MRI (assessing blood flow in the tumor)
- PET with methionine (determination of infiltration boundaries)
- Stereotactic biopsy with histology and:
- IDH1/2 mutation status
- MGMT methylation (prognostic factor)
- Liquid biopsy (ctDNA analysis)
Differential diagnosis:
- Brain metastases
- Brain abscess
- Multiple sclerosis
Each direction is supervised by advanced oncologists.
Find out the cost of treatment
To find out the approximate cost of treatment, answer a few questions and we will contact you!
Treatment methods for glioblastoma
1. Neurosurgery
- Craniotomy with 5-ALA fluorescence (complete resection in 80% of cases)
- Intraoperative MRI (radicality control)
2. Radiation therapy
- Proton therapy (minimal damage to healthy tissue)
- Stereotactic radiosurgery (for relapses)
3. Systemic therapy
- Temozolomide (standard for methylated MGMT)
- Bevacizumab (for pseudoprogression)
- Checkpoint inhibitors (in clinical trials)
4. Maintenance treatment
- Anticonvulsant therapy
- Dexamethasone to reduce swelling
Survival prognosis
- Standard treatment: median survival 14-16 months
- IDH-mutant tumors: 31 months
- MGMT-methylated: 21-24 months
Factors for improving prognosis:
- Young age
- High Karnofsky Index (>70)
- Complete resection
Why choose Germany?
- Leader in neuro-oncology – 5-year survival rate is 8-10% higher than the world average
- Access to innovation – first European use of DCVax-L vaccine
Conclusion
At RheinRegio Klinik Zentrum, individual strategies are used for each glioblastoma patient. We combine radical treatment with preservation of neurological functions.
Sign up for a consultation – we are ready to help in the fight against the disease!
Our clinics
The association of clinics RheinRegio Klinik Zentrum offers the organization of glioblastoma treatment in Germany without intermediaries, providing access to the country’s leading oncology clinics. We combine advanced techniques, an individual approach and the highest level of medical care, giving hope even in difficult cases.
Why RheinRegio Klinik Zentrum?
- Center for Glioma Expertise – participation in international studies (GLORIA, CheckMate 548)
- Intraoperative neuromonitoring – preservation of speech and motor functions
- Personalized regimens – based on tumor molecular profile
- Rehabilitation – cognitive recovery programs
